Epilepsia 50 (Suppl
Biological actions of GLP-1, source: reference [1] Evolution of GLP1 GLP-1RAs Currently, there are nine GLP-1RAs approved for marketing worldwide (Table 1), mainly for the treatment of diabetes and obesity, of which tirzepatide is a novel dual GLP-1RA/GIPR agonist
Biomedicines, 9 (10), 1300
Simple Dosing Regimen
Purity: Higher absorption means fewer fillers are needed to achieve the desired effect
Water, Centella Asiatica Extract (13.5%), Butylene Glycol, Dipropylene Glycol, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Niacinamide (1,000ppm), Glutathione (1,000ppm), Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Beta-Glucan, Hippophae Rhamnoides Fruit Extract, Sodium Hyaluronate, Madecassic Acid, Asiaticoside, Asiatic Acid, Squalane, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Glyceryl Stearate, Cholesterol, Propanediol, Disodium EDTA, Glyceryl Acrylate/Acrylic Acid Copolymer, Cellulose Gum, Xanthan Gum, Inulin, Cellulose, Glucose, Fructose, Polyglucuronic Acid, Hydroxyethyl Urea, Ethylhexylglycerin, Hydroxyacetophenone, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Glycerin, Dipotassium Glycyrrhizate, 1,2-Hexanediol, Carbomer, Arginine
